Labcorp establishes comprehensive laboratory relationship with Ascension

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 3, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the completion of transactions that establish a long-term laboratory relationship with Ascension, one of the leading non-profit and Catholic health systems in the United States.

Labcorp Drug Development selects Dr. Deepa Desai as country head for India

BURLINGTON, N.C., Oct. 3, 2022 — Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointment of Dr. Deepa Desai as senior vice president and country head of Labcorp Drug Development India.